Caplin Point Laboratories Ltd
Caplin Point Laboratories Ltd Company History
Caplin Point Laboratories is into the business of pharmaceuticals - producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas markets.
2010
Caplin Point Laboratories Ltd has recommended a final dividend of Re. 1/- per share (10%)
2010
2011
Caplin Point Laboratories Ltd has Recommended a final Dividend of Re. 1.50 per share (15%)
Mr. Vivek Siddharth has been appointed as the Chief Operating Officer of the Company
2011
2012
Caplin Point Laboratories Ltd has recommended dividend a final dividend of Rs. 2/- per share (20%)
Mr. D. P. Mishra has been appointed as a Whole Time Director of the Company
2012
2013
Mr. Mohanraj has been appointed as the Vice President - Finance and Company Secretary of the company.
2013
2014
Caplin has commenced its additional line of Production in the area of Suppositories which is unique in its feature which very few Pharma Companies have.
Caplin Point Lab gets listing on Forbes Asia and rsquo;s â200 Best Billion and rsquo; 2014.
2014
2015
Caplin Point Lab - Caplin Point gets EU GMP approval for Sterile Injectable Site
Caplin Point Lab - Caplin Point gets Brazil's Anvisa approval for Sterile Injectable Site
2015
2016
Caplin Point Lab - US FDA inspection completed at Caplin Point's Injectable site.
2016
2017
Caplin Point Laboratories received approval from the U.S. Food and Drug Administration (USFDA) of its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection 30mg/mL, a product developed for Cycle Pharmaceuticals.
Caplin Point gets USFDA nod for Ketorolac Tromethamine Injection.
2017
2018
USFDA completes inspection at Caplin Point Lab's sterile injectable facility in Tamil Nadu.
2018
2019
Caplin Point Laboratories partners with Baxter Corporation for injectable portfolio.
USFDA completes inspection at Caplin Steriles Injectable site.
Caplin Steriles gets USFDA nod for hemorrhage prevention drug.
Caplin Point Labs gets EIR from USFDA for injectable facility.
2019
2020
Caplin Point Laboratories Chairman C C Paarthipan said the company has partnered with Xellia which has a long standing track record of commercial success in the US for injectable products.
Caplin Point Laboratories received the final approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) Phenylephrine Hydrochloride injection.
Caplin Point Laboratories Ltd -Caplin Steriles Gets USFDA Approval For Verapamil Hydrochloride Injection USP
2020
2021
Caplin Point arm inks strategic partnership with Canada's JAMP Pharma Group.
Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection.
2021
2023
Lifetime Achievement Award 2023-Business
Forbes Asia Best Under Billion Award 2023
2023
